Skip to content

Comparative randomized clinical trial of Steam Ablation versus Endovenous Laser Ablation for the treatment of Great Saphenous Veins

Comparative randomized clinical trial of Steam Ablation versus Endovenous Laser Ablation for the treatment of Great Saphenous Veins - LAST Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON32935
Enrollment
250
Registered
2009-11-10
Start date
2010-01-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

GSV insufficiency varicose veins

Interventions

Endovenous Laser Ablation or Steam Ablation. Both procedures are endovenous techniques based on heating the varicose vein from inside reulting in closure of the treated vein.

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: primary insufficiency of GSV patients over 18 years old symptoms of chronic venous insufficiency informed consent

Exclusion criteria

Exclusion criteria: agenesis of deep venous system acute deep or superficial vein thrombosis vascular malformation or syndrome post-thrombotic syndrome of occlusive type

Design outcomes

Primary

MeasureTime frame
1. Obliteration of varicose vein and absence of reflux (>0.5 sec. of retrograde flow) along the treated segment of the GSV. This is measured using US examination. The rates will be compared between EVLA and SVS at time 12 and 52 weeks. 2. Varicose Vein Severity score (VVSS), (assessed with a questionnaire).

Secondary

MeasureTime frame
1. Treatment complications: a. Major complications: deep and superficial venous thrombosis (embolic events), nerve injury, skin burns, and (sub)cutaneous infections. b. Minor complications: ecchymosis, pain and hyperpigmentation. The rates will be compared between EVLA and Steam Ablation at time 2 and 12 weeks. 2. Patient reported outcomes: a. Health related quality of life will be measured using the Dutch Aberdeen Questionnaire. b. Treatment satisfaction will be assessed. c. Pain score. 3. Cost-effectiveness analysis (CEA): a. Direct and indirect costs associated with EVLA and Steam Ablation will be estimated. b. Quality adjusted life years will be assessed using the EQ-5D.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)